Canada - Engels - Health Canada

jamp pharma corporation - amitriptyline hydrochloride - tablet - 10mg - amitriptyline hydrochloride 10mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - Engels - Health Canada

jamp pharma corporation - amitriptyline hydrochloride - tablet - 25mg - amitriptyline hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - Engels - Health Canada

jamp pharma corporation - amitriptyline hydrochloride - tablet - 50mg - amitriptyline hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - Engels - Health Canada

jamp pharma corporation - amitriptyline hydrochloride - tablet - 75mg - amitriptyline hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - Engels - Health Canada

angita pharma inc. - amitriptyline hydrochloride - tablet - 10mg - amitriptyline hydrochloride 10mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - Engels - Health Canada

angita pharma inc. - amitriptyline hydrochloride - tablet - 25mg - amitriptyline hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - Engels - Health Canada

angita pharma inc. - amitriptyline hydrochloride - tablet - 50mg - amitriptyline hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - Engels - Health Canada

angita pharma inc. - amitriptyline hydrochloride - tablet - 75mg - amitriptyline hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors

Australië - Engels - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - captopril, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: sodium benzoate; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; disodium edetate; purified water; citric acid - 1.hypertension: capoten (captopril) is indicated for the treatment of hypertension. in using capoten, consideration should be given to the risk of neutropenia/agranulocytosis (see precautions). capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. 2. myocardial infarction: capoten is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond 3 days post-infarct. 3. heart failure: capoten (captopril) is indicated for the treatment of heart failure. in symptomatic patients it is recommended that capoten be administered together with a diuretic. 4. diabetic nephropathy: capoten is indicated for the treatment of diabetic nephropathy in patients with type 1 insulin- dependent diabetes mellitus.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - bendamustine hydrochloride, quantity: 25 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established. previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab. previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patients ineligible for autologous stem cell transplantation. relapsed/refractory indolent non-hodgkin?s lymphoma.